Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®
Go back to Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®| Steel Excel, Inc. (NASDAQ: ADPT) | Delayed: 25.60 +1.18 (4.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.42 | 52 Week High | $73.44 | |||
| Open | $24.36 | 52 Week Low | $7.91 | |||
| Day High | $25.74 | P/E | N/A | |||
| Day Low | $24.25 | EPS | $0.00 | |||
| Volume | 1,274,636 | |||||



